Which of the following is true regarding the use of antivirals during pregnancy?

The reason for selecting that specific answer lies in the understanding of safety profiles associated with different antiviral medications when used during pregnancy. Not all antivirals have been rigorously tested for safety in pregnant individuals, and some can pose risks to the developing fetus.

For instance, certain antivirals may have teratogenic effects, potentially leading to birth defects or other negative pregnancy outcomes. Therefore, healthcare providers often exercise caution and may recommend avoiding specific antivirals altogether depending on the potential risks identified in the existing literature and clinical guidelines.

While some antivirals may be deemed safe for use during pregnancy, their overall categorization varies, and it's crucial to assess each drug individually. This nuanced approach acknowledges that a blanket statement about the safety of all antivirals would be misleading and not representative of the complexities involved in prescribing these medications to pregnant patients.

The other choices suggest either an overly simplistic view of antiviral safety or inaccurately classify the effectiveness and alternatives available for managing viral infections during pregnancy. Recognizing the potential risks associated with specific antivirals allows for a more prudent and balanced approach in managing viral infections in pregnant patients.